We are experiencing extremely high call volume related to COVID-19 vaccine interest. Please understand that our phone lines must be clear for people with urgent and acute medical care needs. Unfortunately, this means we are unable to accept phone calls to schedule COVID-19 vaccinations at this time. When this changes, we will update this web site. Read more COVID-19 Vaccine Information
Johns Hopkins University/National Institutes of Health Pediatric Hematology-Oncology Fellowship
The Johns Hopkins University School of Medicine and the National Cancer Institute represent two of the of the most distinguished pediatric hematology-oncology centers in the world, and their joint fellowship provides exceptional training to six new fellows per year. The program’s mission is to train diversely talented academic physician-scientists who will become leaders in the field of pediatric hematology-oncology.
The program is led by the program director, Stacy Cooper, MD, and the associate program director, Nirali Shah, MD, MHSc. Gladys Valencia Novak and Vicki Richmond serve as fellowship program adminstrators/coordinators.
Fundamental Facets of the Program
Comprehensive training occurs through three complementary clinical exposures
Optimal clinical education is achieved by active patient care in a fellow-centric model
Protected research time essential for productive scholarship during years 2 and 3, and includes the option for a non-clinical, fully funded fourth year of research
World renowned experts in the field are committed to providing dedicated mentorship
Fellow wellness is actively promoted in a potentially emotionally challenging subspecialty
The first year of fellowship is composed of 11 months of clinical training, rotating twice through each one-month block:
The second and third years of fellowship are dedicated to protected research time, with clinical requirements consisting solely of ½ day per week of longitudinal clinic and 4-5 weekends on inpatient hematology.
Fellows have the option to stay on for an optional fourth year of advanced training supported by the JHU T32 grant and NCI slots, which allows for additional dedicated research time as well as an opportunity for focused clinical training in a disease sub-specialty (bone marrow transplant, neuro-oncology, etc.)